Ginsenoside Rb1 and Rd combination and application thereof to preparation of medicine for treating photoreceptor cell death related diseases

A technology of ginsenosides and photoreceptors, applied in sensory diseases, metabolic diseases, drug combinations, etc.
CN106074585AActive Publication Date: 2016-11-09YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
1 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE
Publication Date
2016-11-09

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to application of a ginsenoside Rb1 and Rd combination to preparation of a medicine for treating photoreceptor cell death related diseases. A mouse model suffering from retinal light damage is adopted to simulate the common key pathological links in the process of various degenerative retinal diseases so as to research the intervention effects of the ginsenoside Rb1 and Rd combination on the mouse model suffering from retinal light damage, and the results show that the medicinal combination can maintain the format of the retina outer nuclear layer, effectively prevent the retina outer nuclear layer from degenerative damage and thickness reduction, inhibit death of photoreceptor cells, block oxidative stress of retinal pigment epitheliums and photoreceptor cells, effectively inhibit retinal damage related immuno-inflammatory responses and remarkably improve the degenerative retinal diseases. Therefore, the ginsenoside Rb1 and Rd combination can be used for preparing the medicine for treating various degenerative retinal diseases including age-related macular degeneration, retinal pigment degeneration, Stargardt disease, cone-rod cell dystrophy, diabetic retinopathy and the like.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the technical field of medicine, in particular to the preparation and treatment of the combination of ginsenoside Rb1 and Rd in the treatment of age-related macular degeneration, Stargardt, etc. Retinal degenerative diseases including retinal degeneration, cone-rod dystrophy, retinitis pigmentosa and diabetic retinopathy. Background technique

[0002] Retinal degenerative diseases are a group of fundus diseases with oxidative stress and death of retinal photoreceptor cells and oxidative stress of retinal pigment epithelial cells as the core pathological changes, which can cause visual impairment or even blindness, including age-related macular degeneration, Stargardt disease, cone-rod dystrophy, retinitis pigmentosa, etc. In addition, excessive oxidative stress of photoreceptor cells is an important early pathological link in the occurrence of diabetic retinopathy. Treatment against photoreceptor cell death, retinal p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More